Controversies and advances in the management of ventilator associated pneumonia

Keyphrases

• Antimicrobial 20%
• Antimicrobial Resistance 20%
• Antimicrobial Therapy 20%
• Antimicrobial Use 20%
• Area Cover 20%
• Empirical Therapy 20%
• Expert Commentary 20%
• Health Care Costs 20%
• Hospital-acquired Infection 20%
• Impact-based 20%
• Increasing Prevalence 20%
• Microbial Pathogens 20%
• Microbiological Test 20%
• Multidrug-resistant Bacteria 20%
• National Surveillance Data 20%
• New Antimicrobials 20%
• Nosocomial Infection 20%
• Patient Care 20%
• Patient Outcomes 20%
• Pneumonia Treatment 20%
• Rapid Diagnostic Test 20%
• Testing Method 20%
• Treatment Options 40%
• Treatment Strategy 20%
• United States 20%
• Ventilator-associated Pneumonia 100%

Nursing and Health Professions

• Antiinfective Agent 60%
• Antimicrobial Resistance 20%
• Antimicrobial Therapy 20%
• Diagnosis 40%
• Health Care Cost 20%
• Hospital Infection 40%
• Prevalence 20%
• Treatment Outcome 20%
• Ventilator-Associated Pneumonia 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinfective Agent 60%
• Antimicrobial Resistance 20%
• Antimicrobial Therapy 20%
• Hospital Infection 40%
• Infectious Agent 20%
• Prevalence 20%
• Ventilator Associated Pneumonia 100%